Ipratropium bromide Good Manufacturer supply High Quality 22254-24-6
- Molecular Formula:C20H30NO3.Br
- Molecular Weight:412.42
- Appearance/Colour:white powder
- Melting Point:230-232 °C
- PSA：46.53000
- LogP:-0.18310
Ipratropium bromide (22254-24-6) Usage
Ipratropium bromide, also known as Atrovent, is a quaternary ammonium derivative of atropine. It is a nonselective muscarinic acetylcholine receptor antagonist and a bronchodilator. Ipratropium bromide is freely soluble in water and ethanol but insoluble in chloroform and ether. The salt is stable in neutral and acidic solutions but rapidly hydrolyzed in alkaline solutions. It is a white powder and is used as an anticholinergic drug to block muscarinic cholinergic receptors in the smooth muscles of the bronchi in the lungs, providing relief in chronic obstructive pulmonary disease and acute asthma.
How to get the best price on Ipratropium bromide?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Ipratropium bromide . You can buy high quality, low price Ipratropium bromide 22254-24-6 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
